The transition to Vault CRM positions the pharmaceutical giant to leverage advanced automation in its field engagement strategies. Giuseppe Firenze, senior vice president of U.S. HCP and field engagement at Lilly, noted that the platform is essential for scaling the company's ability to reach more patients effectively. Veeva CEO Peter Gassner echoed the sentiment, emphasizing the role of the new technology suite in supporting Lilly’s global outreach.
In section Releases
Eli Lilly Taps Veeva Vault CRM for Global Commercial Operations
Eli Lilly and Company is shifting its global commercial operations to Veeva Vault CRM, marking a significant expansion of its partnership with the cloud software provider. The move centers on adopting an agentic commercial model, an AI-driven framework designed to accelerate the delivery of breakthrough medicines to a broader patient population.
This platform upgrade integrates the Vault CRM Suite, which includes tools like the Agentic Call Report intended to generate commercial evidence. For Veeva, the agreement underscores the growing adoption of its industry-specific cloud services among large-scale pharmaceutical firms as they seek to digitize and optimize field force operations.
Comments (0)
No comments yet. Be the first!